Mibelle Biochemistry announces: Mibelle Biochemistrys Ability to Introduce Breakthrough Active Ingredients for the Personal Care Market by Frost and…

18-Nov-2020 Ingredients | Marketing The company's active ingredient product lines meet consumer expectations of quality, performance andsustainability Based on its recent analysis of the global personal care active ingredients market, Frost & Sullivan recognises Mibelle AG Biochemistry with the 2020 Global Company of the Year Award. It has successfully introduced several breakthrough sustainable active ingredients, whose efficacy is supported by in-vivo and in-vitro study results. Mibelle Biochemistry is a pioneer with regards to using senolytics to delay skin aging in cosmetic applications, which has helped the company achieve a leading positioning in the market.

Read more
Cynata Therapeutics (ASX:CYP) begins phase three osteoarthritis trial – The Market Herald

Cynata Therapeutics (CPY) has begun its phase three osteoarthritis clinical trial using its Cymerus mesenchymal stem cell (MSC) product, CYP-004. The trial is sponsored by the University of Sydney and is funded by an Australian Government National Health and Medical Research Council (NHMRC) grant. It will take place at study centres in Sydney and Tasmania and will begin with an initial four patients who will be assessed over a four week period

Read more
Mesenchymal Stem Cells Market Industry Outline, Executive Manufacturers, Interpretation and Benefit Growth 2026 by Lonza, Thermo Fisher, Bio-Techne,…

Global Mesenchymal Stem Cells Market Research Report 2020-2026 provides a comprehensive assessment of the Mesenchymal Stem Cells Market for the forecast from 2020 to 2026, as well as market values for the years 2018 and 2019. The investigatory report provides a close analysis of the impact of COVID-19 on numerous segments within the Mesenchymal Stem Cells market supported product kind, application, and end-use across various countries round the world.

Read more
Mesenchymal Stem Cells Market To Witness Huge Growth By 2027 | Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis,…

A new research study has been presented by Industrygrowthinsights.com offering a comprehensive analysis on the Global Mesenchymal Stem Cells Market where user can benefit from the complete market research report with all the required useful information about this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally

Read more
Exosome Therapeutic Market 2020-2026 Growth Overview, New Updates, Opportunities and Challenges || Major Gaints Jazz Pharmaceuticals, Inc.,…

In Exosome Therapeutic Market report, a systematic investment analysis has been performed which forecasts impending opportunities for the market players. The statistical and numerical data that has been included in this market report is represented with the tables, graphs and charts which eases the understanding of facts and figures.

Read more
BioCardia Reports Third Quarter 2020 Financial Results and Business Highlights – GlobeNewswire

SAN CARLOS, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- BioCardia, Inc.[NASDAQ: BCDA], a leader in the development of autologous and allogenic cell therapies, today reported financial results and business highlights for the third quarter of 2020 and filed its quarterly report on Form 10-Q for the three and nine months ended September 30, 2020 with the Securities and Exchange Commission on November 10, 2020.

Read more
Consumer Demand for Eco-friendly Products Set to Boost the Prospects of the Mesenchymal Stem Cells Market2020 – Zenit News

Most recent report on the global Mesenchymal Stem Cells market by PMR A recent market study by PMR reveals that the global Mesenchymal Stem Cells market is likely to grow at a CAGR of ~XX% over the forecast period (2019-2029) largely driven by factors including, factor 1, factor 2, factor 3, and factor 4.

Read more